Method
Level · gp.fundamentals.capex_revenue_ratio
Raw value 20.74% · OPTIONAL
· Surgical & Medical Instruments & Apparatus
RESEARCH SNAPSHOTPULSE BIOSCIENCES, INC.'s latest supported as-filed period reports revenue of $434,000. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 20.74% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -4310.83% · OPTIONAL
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 54.38% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 37.10% · CORE
Level · gp.fundamentals.operating_margin
Raw value -5823.04% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 3911.52% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Research & development changed +40.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed -24.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
PLSE · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001437749-26-029545SEC ↗4Aug 28, 2026Period Aug 26, 20260001437749-26-029233SEC ↗4Aug 28, 2026Period Apr 8, 20260001437749-26-029231SEC ↗4Aug 28, 2026Period Feb 3, 20250001437749-26-029220SEC ↗8-KAug 6, 2026Period Aug 6, 20260001437749-26-026351SEC ↗10-QAug 6, 2026Period Jun 30, 20260001437749-26-026288SEC ↗8-KAug 6, 2026Period Aug 6, 20260001437749-26-026256SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Sep 1, 2026Filed Sep 2, 2026 | Teplitsky Liane RaeChief Operating Officer | Open Market PurchaseDirect | 1,001 | $50 | $50,000 | Form 4 ↗ |
| Aug 31, 2026Filed Sep 2, 2026 | Teplitsky Liane RaeChief Operating Officer | Open Market PurchaseDirect | 1,024 | $49 | $49,971 | Form 4 ↗ |
| Aug 28, 2026Filed Aug 28, 2026 | Teplitsky Liane RaeChief Operating Officer | Open Market PurchaseDirect | 1,034 | $48 | $49,994 | Form 4 ↗ |
| Aug 26, 2026Filed Aug 28, 2026 | Teplitsky Liane RaeChief Operating Officer | Open Market PurchaseDirect | 1,036 | $48 | $49,971 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Raw value 1145.85% · OPTIONAL
Net income changed -28.6% from the comparable as-filed period.
Inventory changed +362.7% from the comparable as-filed period.
Revenue changed +0.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
Cash & equivalents changed -4.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Stock-based compensation changed -4.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001437749-26-024758| Aug 8, 2026Filed Aug 28, 2026 |
| Teplitsky Liane RaeChief Operating Officer |
| Grant Or AwardDirect |
| 200,000 |
| $0 |
| $0 |
| Form 4 ↗ |
| Aug 8, 2026Filed Aug 28, 2026 | Teplitsky Liane RaeChief Operating Officer | Grant Or AwardDirect | 700,000 | $0 | $0 | Form 4 ↗ |
| Jun 11, 2026Filed Jun 15, 2026 | Zanganeh MahkamDirector | Grant Or AwardDirect | 30,000 | $0 | $0 | Form 4 ↗ |
| Jun 11, 2026Filed Jun 15, 2026 | Zanganeh MahkamDirector | Grant Or AwardDirect | 14,504 | $0 | $0 | Form 4 ↗ |
| Jun 11, 2026Filed Jun 15, 2026 | DUGGAN ROBERT WDirector | Grant Or AwardDirect | 12,495 | $0 | $0 | Form 4 ↗ |
| Jun 11, 2026Filed Jun 15, 2026 | van den Broek RichardDirector | Grant Or AwardDirect | 30,000 | $0 | $0 | Form 4 ↗ |
| Jun 11, 2026Filed Jun 15, 2026 | van den Broek RichardDirector | Grant Or AwardDirect | 8,423 | $0 | $0 | Form 4 ↗ |
| Jun 11, 2026Filed Jun 15, 2026 | DUGGAN ROBERT WDirector | Grant Or AwardDirect | 30,000 | $0 | $0 | Form 4 ↗ |
| Jun 11, 2026Filed Jun 15, 2026 | Soni Manmeet SinghDirector | Grant Or AwardDirect | 30,000 | $0 | $0 | Form 4 ↗ |
| Jun 11, 2026Filed Jun 15, 2026 | Sainz MariaDirector | Grant Or AwardDirect | 30,000 | $0 | $0 | Form 4 ↗ |
| Jun 11, 2026Filed Jun 15, 2026 | Sainz MariaDirector | Grant Or AwardDirect | 3,793 | $0 | $0 | Form 4 ↗ |
| May 11, 2026Filed May 15, 2026 | DUGGAN ROBERT WDirector | Open Market PurchaseDirect · amended | 660,233 | $20 | $13.0M | Form 4 ↗ |
| May 11, 2026Filed May 11, 2026 | LAVIOLETTE PAUL AChief Executive Officer | Open Market PurchaseDirect · amended | 15,000 | $20 | $295,350 | Form 4 ↗ |
| May 11, 2026Filed May 11, 2026 | LAVIOLETTE PAUL AChief Executive Officer | Open Market PurchaseDirect | 15,000 | $20 | $295,350 | Form 4 ↗ |
| May 11, 2026Filed May 11, 2026 | DUGGAN ROBERT WDirector | Open Market PurchaseDirect | 660,233 | $20 | $13.0M | Form 4 ↗ |
| Feb 3, 2025Filed Aug 28, 2026 | Skinner JonChief Financial Officer | Grant Or AwardDirect | 300,000 | $0 | $0 | Form 4 ↗ |